By measuring the mutations of particular alleles we are able to determine patients as ultra
metabolizers, normal metabolizers, intermediate metabolizers, and poor metabolizers. This information itself is enough to reduce the current endemic surrounding adverse drug reactions ($177 billion is currently spent on these maladies). The problem henceforth lies in educating the physician and patient.
Ally Clinical Diagnostics will set your practice apart by giving you compliance and operating assurances previously unknown in the field. Understanding your patient’s genetic makeup enables you to tailor a specific prescription plan, be it painkillers, antidepressants, or anxiety medication, while helping to avoid any unnecessary harm that may be done. This provides a great alternative to the trial and error method used by physicians today, when determining which prescription drugs work best for their patients and which do not.
Ally Clinical Diagnostics would appreciate nothing more than having physicians come and see our technology at work. Our doors are always open. With outreach and support from the community, let us see if we can work together with physicians to educate our future and avoid costly adverse drug reactions, saving our citizens’ health and money.
“Determining the genetic makeup of a patient gives important insight into which medications and dosages will give the greatest benefit to patients without adverse drug reactions.”
– Dr. Rhiannon Gonzalez
Adverse Drug Reactions are the 4th leading cause of death and 5th leading cause
of illness with over 2 million ADR’s occurring annually. Ally Clinical Diagnostics has
the responsibility to support the fields of psychiatry, oncology, pain management,
and coagulation to help physicians identify deficiencies while avoiding unwarranted side effects and even death due to a uncalculated prescription module for a patient. No two persons are exactly alike so why, in turn, should their treatments follow this line of thought?